Projects IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities. Breadcrumb Home Projects Keywords Research group - Any -Cell Virology and Immunology (VIC)HIV and HVC Genetic and Phenotypic VariabilityImmunology (IGG)Microbial Genomics (GEM)Neoantigens and Vaccines against Cancer (NeoVaCan)Pathogen Immunity, Signalling and Therapeutic Applications (PISTA)Retrovirology and Clinical Studies (GREC)T-cell Immunology and Vaccines (TIV)Tissue Virology (VITI)Translational Research in Immunology and Ageing (TRIA)Viral Immune Evasion and Vaccines (VIRIEVAC)Virus-Host Interactions (ViHIT) Researcher - Any -Aleix Elizalde TorrentAlejandro Riquelme GrauAlessandra BorgognoneAlex Olvera van der StoepAna Barajas MolinaAnaí Villanueva DelgadoAnna López PlanaAnna Pons GrifolsArnau Creus OrodeaBeatriz Mothe PujadasBenjamin TrinitéBonaventura Clotet SalaCarla Rovirosa MartíCarlos Ávila NietoCarmen Aguilar GurrieriCecilia Cabrera NavarroChristian BranderCristina GálvezCristina Mesa RealCristina Peligero CruzCristina Ramírez SotoDaniela Benítez CanoDaniel Pérez ZsoltDàlia Raïch ReguéEdurne García VidalEdwards Pradenas SaavedraElena Lapaz LorenzoElisabet Fernández RosasElisabet García RodríguezElisa Molina MolinaErola Ainsua EnrichEster Ballana GuixEudald Felip FalgàsEudald Vehí PiquéEulalia Grau SegúEva Riveira MuñozFernando Laguía NuedaFerran Abancó i EspugaFrancesc Català MollFrancisco M. Muñoz LópezGabriel Felipe Rodríguez LozanoGerard Campos GonzalezGustavo Rodríguez EstebanIgnasi Calba IñiguezIgor Moraes CardosoIrene González NavarroItziar Erkizia JauregiJakub ChojnackiJavier Martínez-PicadoJoan Pagès OliverasJon Izquierdo PujolJordi Senserrich VelascoJorge Carrillo MolinaJosé Luis Pérez GuillamónJudith Dalmau MorenoJulia García PradoJulieta CarabelliJulià Blanco ArbuésJulián Eslava CampoJúlia Albó DelgadoLaia Bernad RosaLaia Vives AdriánLaura Planells FerrerLidia Garrido SanzLidia Ruiz TabuencaLluís Revilla SanchoLourdes Grau ParéLucía Gutiérrez ChamorroLucía Gómez EspadaMacedonia Trigueros PeñaManel Garcia de la FuenteMarc Noguera i JulianMaria Casadellà FontdevilaMaria Nevot BanúsMaria Salgado BernalMarina Pino CebriánMariona Parera SallentMarissa Flores SantamaríaMarta Massanella LunaMarta Navarro GutiérrezMarta Ruiz RiolMaría Lázaro DíezMiguel Marín LópezMiguel Ángel Martínez de la SierraMireia Martínez GameroMª Carmen García GuerreroMª Carmen Puertas CastroMª Luisa Rodríguez de la ConcepciónNatàlia Marrugat VilaNuria Izquierdo UserosNúria de la Iglesia ZaragozaNúria Pedreño LópezPatricia Piñol JuradoPatricia Resa InfantePenélope Riquelme NevadoPep Coll VerdRafaela Ayen AparicioRaúl Pérez CaballeroRita Casas CostaRoger Badia CórcolesRoger ParedesRosina Malagrida EscalasRuth Peña PoderósRytis BoreikaSamandhy Cedeño BriceñoSandra Franco CireraSandra Silva ArrietaSara Cabrero de las HerasSara Morón LópezSilvia Marfil VerchiliSonia Bange SinghSusana Esteban RayaSílvia Ribó GenéTeresa Puig OlivaTetyana PidkovaToni Navarro AlcarazTuixent Escribà BelValentina Triviño VenceVíctor Urrea GalesÁngel Bayón Gil From date To date RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118 Incorporation of a new subject and new groups to the Consortium of the Centro de Investigación Biomédica en Red M.P. (CIBER) Project status Ongoing Start/End 2022 Principal investigator Julia García Prado Javier Martínez-Picado Participating entities IrsiCaixa, IGTP Financing entity ISCIII Preclinical evaluation of immunoregulatory molecules in combination with latency reactivators for the development of new HIV-1 erradication strategies Project status Ongoing Start/End 2015 / 2018 Principal investigator Julia García Prado Financing entity Ministry of the Economy and Competitiveness - Carlos III Health Institute (ISCIII) - FEDER. PI14/01058 LKR155762 Combine use of vaccines an immune check blockers to boost CTL activity against the reservoir Project status Ongoing Start/End 2017 / 2019 Principal investigator Julia García Prado Financing entity MSD Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp Project status Ongoing Start/End Principal investigator Nuria Izquierdo Useros Participating entities Irsicaixa, ICN2, UPV-CSIC Financing entity MINECO Connecting innate and adaptive immunity via TRIM5 proteins for cellular resistance to HIV Project status Ongoing Start/End Principal investigator Julia García Prado Financing entity Beatriu de Pinós post-doctoral fellowship, AGAUR CELLRE - TRIM5-based gene therapy approaches for inducible cellular resistance to HIV-1 Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols RECOVIR - Breaking the Immune Exhaustion Barrier to Recover Antiviral Immunity for the HIV-1 Cure Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols Novel bispecific Trimerbody targeting human 4-1BB and Env for immunotherapy based HIV-1 curative therapeutics Project status Ongoing Start/End 2020 / 2022 Principal investigator Julia García Prado Participating entities IrsiCaixa, Hospital 12 de Octubre research institute Identification and characterization of T cell protective responses against CoV2. ISCIII COV20/0660 Project status Ongoing Start/End 2021 / 2022 Principal investigator Julia García Prado Financing entity Instituto de Salud Carlos III (ISCIII) Pagination 1 Page 2 Next Last
RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118
Incorporation of a new subject and new groups to the Consortium of the Centro de Investigación Biomédica en Red M.P. (CIBER) Project status Ongoing Start/End 2022 Principal investigator Julia García Prado Javier Martínez-Picado Participating entities IrsiCaixa, IGTP Financing entity ISCIII
Preclinical evaluation of immunoregulatory molecules in combination with latency reactivators for the development of new HIV-1 erradication strategies Project status Ongoing Start/End 2015 / 2018 Principal investigator Julia García Prado Financing entity Ministry of the Economy and Competitiveness - Carlos III Health Institute (ISCIII) - FEDER. PI14/01058
LKR155762 Combine use of vaccines an immune check blockers to boost CTL activity against the reservoir Project status Ongoing Start/End 2017 / 2019 Principal investigator Julia García Prado Financing entity MSD
Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp Project status Ongoing Start/End Principal investigator Nuria Izquierdo Useros Participating entities Irsicaixa, ICN2, UPV-CSIC Financing entity MINECO
Connecting innate and adaptive immunity via TRIM5 proteins for cellular resistance to HIV Project status Ongoing Start/End Principal investigator Julia García Prado Financing entity Beatriu de Pinós post-doctoral fellowship, AGAUR
CELLRE - TRIM5-based gene therapy approaches for inducible cellular resistance to HIV-1 Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols
RECOVIR - Breaking the Immune Exhaustion Barrier to Recover Antiviral Immunity for the HIV-1 Cure Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols
Novel bispecific Trimerbody targeting human 4-1BB and Env for immunotherapy based HIV-1 curative therapeutics Project status Ongoing Start/End 2020 / 2022 Principal investigator Julia García Prado Participating entities IrsiCaixa, Hospital 12 de Octubre research institute
Identification and characterization of T cell protective responses against CoV2. ISCIII COV20/0660 Project status Ongoing Start/End 2021 / 2022 Principal investigator Julia García Prado Financing entity Instituto de Salud Carlos III (ISCIII)